Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-28T17:13:46.600Z Has data issue: false hasContentIssue false
  • English
  • Français

Minor physical anomalies and craniofacial measures in patients with treatment-resistant schizophrenia

Published online by Cambridge University Press:  17 December 2014

A.-S. Lin ,
S.-S. Chang ,
S.-H. Lin ,
Y.-C. Peng ,
H.-G. Hwu  and
W. J. Chen
A.-S. Lin
Affiliation:
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei 100, Taiwan Department of Psychiatry, Cardinal Tien Hospital, New Taipei City, Taiwan Department of General Psychiatry, Bali Psychiatric Center, Ministry of Health and Welfare, New Taipei City, Taiwan
S.-S. Chang
Affiliation:
Hong Kong Jockey Club Centre for Suicide Research and Prevention, University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China Ju Shan Hospital, Taoyuan, Taiwan
S.-H. Lin
Affiliation:
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Y.-C. Peng
Affiliation:
Department of General Psychiatry, Bali Psychiatric Center, Ministry of Health and Welfare, New Taipei City, Taiwan
H.-G. Hwu
Affiliation:
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei 100, Taiwan Department of Psychiatry, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
W. J. Chen*
Affiliation:
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei 100, Taiwan Department of Psychiatry, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
*
*Address for correspondence: W. J. Chen, M.D., Sc.D., Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei 100, Taiwan. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Schizophrenia patients have higher rates of minor physical anomalies (MPAs) than controls, particularly in the craniofacial region; this difference lends support to the neurodevelopmental model of schizophrenia. Whether MPAs are associated with treatment response in schizophrenia remains unknown. The aim of this case–control study was to investigate whether more MPAs and specific quantitative craniofacial features in patients with schizophrenia are associated with operationally defined treatment resistance.

Method

A comprehensive scale, consisting of both qualitatively measured MPAs and quantitative measurements of the head and face, was applied in 108 patients with treatment-resistant schizophrenia (TRS) and in 104 non-TRS patients. Treatment resistance was determined according to the criteria proposed by Conley & Kelly (2001; Biological Psychiatry 50, 898–911).

Results

Our results revealed that patients with TRS had higher MPA scores in the mouth region than non-TRS patients, and the two groups also differed in four quantitative measurements (facial width, lower facial height, facial height, and length of the philtrum), after controlling for multiple comparisons using the false discovery rate. Among these dysmorphological measurements, three MPA item types (mouth MPA score, facial width, and lower facial height) and earlier disease onset were further demonstrated to have good discriminant validity in distinguishing TRS from non-TRS patients in a multivariable logistic regression analysis, with an area under the curve of 0.84 and a generalized R2 of 0.32.

Conclusions

These findings suggest that certain MPAs and craniofacial features may serve as useful markers for identifying TRS at early stages of the illness.

Keywords

Discriminant validityectodermal morphogenesisminor physical anomaliesneurodevelopmentschizophreniatreatment resistance
Type
Original Articles
Information
Psychological Medicine , Volume 45 , Issue 9 , July 2015 , pp. 1839 - 1850
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aksoy-Poyraz, C, Poyraz, BC, Turan, S, Arikan, MK (2011). Minor physical anomalies and neurological soft signs in patients with schizophrenia and their siblings. Psychiatry Research 190, 85–90.Google Scholar
Altamura, AC, Bassetti, R, Cattaneo, E, Vismara, S (2005). Some biological correlates of drug resistance in schizophrenia: a multidimensional approach. World Journal of Biological Psychiatry 6 (Suppl. 2), 23–30.Google Scholar
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn, text revision. American Psychiatric Association: Washington, DC.Google Scholar
Benjamini, Y, Drai, D, Elmer, G, Kafkafi, N, Golani, I (2001). Controlling the false discovery rate in behavior genetics research. Behavioral Brain Research 125, 279–284.Google Scholar
Bilic, P, Jukic, V, Vilibic, M, Savic, A, Bozina, N (2014). Treatment-resistant schizophrenia and DAT and SERT polymorphisms. Gene 543, 125–132.Google Scholar
Carlson, BM (2009). Human Embryology and Developmental Biology, 4th edn. Mosby/Elsevier: Philadelphia, PA.Google Scholar
Compton, MT, Bollini, AM, McKenzie Mack, L, Kryda, AD, Rutland, J, Weiss, PS, Bercu, Z, Esterberg, ML, Walker, EF (2007). Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophrenia Research 94, 64–73.CrossRefGoogle ScholarPubMed
Compton, MT, Chan, RC, Walker, EF, Buckley, PF (2011). Minor physical anomalies: potentially informative vestiges of fetal developmental disruptions in schizophrenia. International Journal of Developmental Neuroscience 29, 245–250.CrossRefGoogle ScholarPubMed
Compton, MT, Walker, EF (2009). Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia? Schizophrenia Bulletin 35, 425–436.Google Scholar
Conley, RR, Kelly, DL (2001). Management of treatment resistance in schizophrenia. Biological Psychiatry 50, 898–911.Google Scholar
Dean, K, Fearon, P, Morgan, K, Hutchinson, G, Orr, K, Chitnis, X, Suckling, J, Mallet, R, Leff, J, Jones, PB, Murray, RM, Dazzan, P (2006). Grey matter correlates of minor physical anomalies in the AeSOP first-episode psychosis study. British Journal of Psychiatry 189, 221–228.Google Scholar
Demjaha, A, Murray, RM, McGuire, PK, Kapur, S, Howes, OD (2012). Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. American Journal of Psychiatry 169, 1203–1210.Google Scholar
Elizarraras-Rivas, J, Fragoso-Herrera, R, Cerdan-Sanchez, LF, Ramos-Zepeda, R, Barajas-Barajas, LO, Troyo-Sanroman, R, McLean, D, McGrath, JJ (2003). Minor physical anomalies and anthropometric measures in schizophrenia: a pilot study from Mexico. Schizophrenia Research 62, 285–287.Google Scholar
Elkis, H (2007). Treatment-resistant schizophrenia. Psychiatric Clinics of North America 30, 511–533.Google Scholar
Farkas, LG (1981). Anthropometry of the Head and Face in Medicine. Elsevier Science: New York.Google Scholar
Fatemi, SH, Folsom, TD (2009). The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophrenia Bulletin 35, 528–548.CrossRefGoogle ScholarPubMed
Gardner, DM, Murphy, AL, O'Donnell, H, Centorrino, F, Baldessarini, RJ (2010). International consensus study of antipsychotic dosing. American Journal of Psychiatry 167, 686–693.Google Scholar
Golembo-Smith, S, Schiffman, J, Kline, E, Sorensen, HJ, Mortensen, EL, Stapleton, L, Hayashi, K, Michelsen, NM, Ekstrom, M, Mednick, S (2012). Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizophrenia-spectrum disorder: a high-risk prospective investigation. Schizophrenia Research 139, 129–135.Google Scholar
Goodman, RM, Gorlin, RJ (1983). The Malformed Infant and Child: An Illustrated Guide. Oxford University Press: New York.Google Scholar
Gorlin, RJ, Cohen, MM Jr, Levin, LS (1990). Syndromes of the Head and Neck, 3rd edn. Oxford University Press: New York.Google Scholar
Gourion, D, Goldberger, C, Bourdel, M-C, Bayle, FJ, Lôo, H, Krebs, M-O (2004). Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Research 125, 21–28.Google Scholar
Green, MF, Satz, P, Gaier, DJ, Ganzell, S, Kharabi, F (1989). Minor physical anomalies in schizophrenia. Schizophrenia Bulletin 15, 91–99.Google Scholar
Guy, W (1976). ECDEU Assessment Manual for Psychopharmacology, p. 217–222. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs: Rockville, MD.Google Scholar
Hall, JG, Froster-Iskenius, UG, Allanson, JE (1989). Handbook of Normal Physical Measurements. Oxford University Press: New York.Google Scholar
Hata, K, Iida, J, Iwasaka, H, Negoro, HI, Ueda, F, Kishimoto, T (2003). Minor physical anomalies in childhood and adolescent onset schizophrenia. Psychiatry and Clinical Neurosciences 57, 17–21.CrossRefGoogle ScholarPubMed
Henriksson, KM, Kelly, BD, Lane, A, Agartz, I, Nesvag, R, Cantor-Graae, E, O'Callaghan, E, McNeil, TF (2008). Minor physical anomalies in schizophrenia: is age a confounding factor? Psychological Medicine 38, 154–156.Google Scholar
Huang, CJ, Chiu, HJ, Lan, TH, Wang, HF, Kuo, SW, Chen, SF, Yu, YH, Liu, YR, Hu, TM, Loh E, W (2009). Significance of morphological features in schizophrenia of a Chinese population. Journal of Psychiatric Research 44, 63–68.Google Scholar
Ismail, B, Cantor-Graae, E, McNeil, TF (1998). Minor physical anomalies in schizophrenic patients and their siblings. American Journal of Psychiatry 155, 1695–1702.Google Scholar
Ismail, B, Cantor-Graae, E, McNeil, TF (2000). Minor physical anomalies in schizophrenia: cognitive, neurological and other clinical correlates. Journal of Psychiatric Research 34, 45–56.Google Scholar
John, JP, Arunachalam, V, Ratnam, B, Isaac, MK (2008). Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers. Comprehensive Psychiatry 49, 78–86.Google Scholar
Kane, JM, Leucht, S, Carpenter, D, Docherty, JP (2003). The expert consensus guideline series: optimizing pharmacologic treatment of psychotic disorders. Journal of Clinical Psychiatry 64, 2–97.Google Scholar
Kay, SR, Fiszbein, A, Opler, LA (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.Google Scholar
Kelly, BD, Lane, A, Agartz, I, Henriksson, KM, McNeil, TF (2005). Craniofacial dysmorphology in Swedish schizophrenia patients. Acta Psychiatrica Scandinavica 111, 202–207.Google Scholar
Lane, A, Kinsella, A, Murphy, P, Byrne, M, Keenan, J, Colgan, K, Cassidy, B, Sheppard, N, Horgan, R, Waddington, JL, Larkin, C, O'Callaghan, E (1997). The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychological Medicine 27, 1155–1164.CrossRefGoogle ScholarPubMed
Lloyd, T, Dazzan, P, Dean, K, Park, SB, Fearon, P, Doody, GA, Tarrant, J, Morgan, KD, Morgan, C, Hutchinson, G, Leff, J, Harrison, G, Murray, RM, Jones, PB (2008). Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity. Psychological Medicine 38, 71–77.CrossRefGoogle ScholarPubMed
Lloyd, T, Doody, G, Brewin, J, Park, B, Jones, P (2003). Minor physical anomalies in schizophrenia: is age a confounding factor? Schizophrenia Research 61, 67–73.Google Scholar
Lohr, JB, Flynn, K (1993). Minor physical anomalies in schizophrenia and mood disorders. Schizophrenia Bulletin 19, 551–556.Google Scholar
McGrath, J, El-Saadi, O, Grim, V, Cardy, S, Chapple, B, Chant, D, Lieberman, D, Mowry, B (2002). Minor physical anomalies and quantitative measures of the head and face in patients with psychosis. Archives of General Psychiatry 59, 458–464.Google Scholar
McGrath, JJ, van Os, J, Hoyos, C, Jones, PB, Harvey, I, Murray, RM (1995). Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables. Schizophrenia Research 18, 9–20.Google Scholar
Murphy, KC (2002). Schizophrenia and velo-cardio-facial syndrome. Lancet 359, 426–430.Google Scholar
Murray, RM, O'Callaghan, E, Castle, DJ, Lewis, SW (1992). A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin 18, 319–332.CrossRefGoogle Scholar
O'Callaghan, E, Buckley, P, Madigan, C, Redmond, O, Stack, JP, Kinsella, A, Larkin, C, Ennis, JT, Waddington, JL (1995). The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging. Biological Psychiatry 38, 516–524.Google Scholar
Rapoport, JL, Addington, AM, Frangou, S, Psych, MR (2005). The neurodevelopmental model of schizophrenia: update 2005. Molecular Psychiatry 10, 434–449.Google Scholar
Reynolds, GP (2012). The pharmacogenetics of symptom response to antipsychotic drugs. Psychiatry Investigation 9, 1–7.Google Scholar
Schacht, A, Bogaerts, K, Bluhmki, E, Lesaffre, E (2008). A new nonparametric approach for baseline covariate adjustment for two-group comparative studies. Biometrics 64, 1110–1116.Google Scholar
Sheitman, BB, Lieberman, JA (1998). The natural history and pathophysiology of treatment resistant schizophrenia. Journal of Psychiatric Research 32, 143–150.Google Scholar
Smith, DW (1982). Recognizable Patterns of Human Malformation, 3rd edn. WB Saunders: Philadelphia, PA.Google Scholar
Tarrant, CJ, Jones, PB (1999). Precursors to schizophrenia: do biological markers have specificity? Canadian Journal of Psychiatry 44, 335–349.Google Scholar
Trixler, M, Tenyi, T, Csabi, G, Szabo, R (2001). Minor physical anomalies in schizophrenia and bipolar affective disorder. Schizophrenia Research 52, 195–201.Google Scholar
Tsuang, MT, Faraone, SV (1995). The case for heterogeneity in the etiology of schizophrenia. Schizophrenia Research 17, 161–175.Google Scholar
Waddington, JL, Buckley, PF, Scully, PJ, Lane, A, O'Callaghan, E, Larkin, C (1998). Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics? Journal of Psychiatric Research 32, 179–189.Google Scholar
Waddington, JL, Lane, A, Larkin, C, O'Callaghan, E (1999a). The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease. Biological Psychiatry 46, 31–39.Google Scholar
Waddington, JL, Lane, A, Scully, P, Meagher, D, Quinn, J, Larkin, C, O'Callaghan, E (1999b). Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to ‘neuroprogressive’ process. Journal of Psychiatric Research 33, 477–489.Google Scholar
Waldrop, MF, Pedersen, FA, Bell, RQ (1968). Minor physical anomalies and behavior in preschool children. Child Development 39, 391–400.CrossRefGoogle ScholarPubMed
Weinberg, SM, Jenkins, EA, Marazita, ML, Maher, BS (2007). Minor physical anomalies in schizophrenia: a meta-analysis. Schizophrenia Research 89, 72–85.CrossRefGoogle ScholarPubMed
Weinberger, DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44, 660–669.Google Scholar
Xu, T, Chan, RC, Compton, MT (2011). Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis. PLoS ONE 6, e24129.Google Scholar
Yoshitsugu, K, Yamada, K, Toyota, T, Aoki-Suzuki, M, Minabe, Y, Nakamura, K, Sekine, Y, Suzuki, K, Takei, N, Itokawa, M, Mori, N, Yoshikawa, T (2006). A novel scale including strabismus and ‘cuspidal ear’ for distinguishing schizophrenia patients from controls using minor physical anomalies. Psychiatry Research 145, 249–258.Google Scholar
Zhang, JP, Lencz, T, Geisler, S, DeRosse, P, Bromet, EJ, Malhotra, AK (2013). Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia. Schizophrenia Research 146, 285–288.Google Scholar
Zugman, A, Gadelha, A, Assuncao, I, Sato, J, Ota, VK, Rocha, DL, Mari, JJ, Belangero, SI, Bressan, RA, Brietzke, E, Jackowski, AP (2013). Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia. Schizophrenia Research 148, 81–86.Google Scholar
Supplementary material: File

Lin Supplementary Material

Table S1 and Figure S1

Download Lin Supplementary Material(File)
File 68.4 KB